DUBLIN, Ireland, May 2, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its Board of Directors has voted unanimously to appoint Paul Herendeen, the Company's Executive Vice President and Chief Financial Officer, to the Company's Board effective as of May 2, 2013. Mr. Herendeen will continue to serve as Executive Vice President and Chief Financial Officer of the Company.
Mr. Herendeen joined Warner Chilcott as Executive Vice President and Chief Financial Officer in April 2005 and is responsible for the Company's finance, accounting and treasury functions. From April 2001 until March of 2005, he was Executive Vice President and Chief Financial Officer of MedPointe, Inc., now part of Meda AB. From 1996 through March of 2001, he served in various capacities with Warner Chilcott's predecessor companies including as a director and Executive Vice President from 1996 to 2001 and as Chief Financial Officer from 1997 to 2000. He holds an M.B.A. from the University of Virginia Darden School Of Business and a B.S. from Boston College.
The Company also announced that, effective May 2, 2013, Liam M. Fitzgerald resigned from the Board. Mr. Fitzgerald's resignation was not the result of any disagreement between the Company and Mr. Fitzgerald on any matter relating to the Company's operations, policies or practices.The Company's Chief Executive Officer and President, Roger Boissonneault, commented, "The other members of Warner Chilcott's Board and I thank Liam for the contributions that he has made to the Company and wish him well in his future endeavors. We also welcome Paul to the Board. Paul has made extraordinary contributions to Warner Chilcott over the last eight years and in his prior service to the Company. We look forward to his continued contributions to Warner Chilcott at this level." The Company Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America. The Company is a fully integrated company with internal resources dedicated to the development, manufacture and promotion of its products. WCRX-G